Skip to main content
. Author manuscript; available in PMC: 2016 Apr 2.
Published in final edited form as: Breast Cancer Res Treat. 2015 Apr 2;150(3):569–579. doi: 10.1007/s10549-015-3359-6

Figure 1. PARP1 expression is altered at the genomic and protein levels in HER2+ breast cancer patients from the TCGA PAM50 set.

Figure 1

a) cBioPortal analysis of PARP1/PARP2 mRNA expression in HER2+-overexpressing breast cancer patients. b) cBioPortal analysis of PARP1/PARP2 mRNA expression in basal breast cancer patients. c) cBioPortal analysis of PARP1/PARP2 mRNA expression in luminal A/B breast cancer patients. d) PARP1 protein expression is elevated in HER2+-overexpressing breast cancer patients with genomically altered PARP1 (p = 0.003). e) PARP1 protein expression is elevated in basal breast cancer patients with genomically altered PARP1 (p = 0.027). f) PARP1 protein expression is not altered in luminal A/B breast cancer patients (p = 0.289).